Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0001415889-24-023709

PRESIDENT AND CEO sold 100,000 shares at an average $12.93 ($1,293,205)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lowenthal Richard E PRESIDENT AND CEO 2024-09-17 Sale 10b5-1 −50,000 $12.93 $646,525 1,447,447 I
Lowenthal Richard E PRESIDENT AND CEO 2024-09-17 Sale 10b5-1 −50,000 $12.93 $646,680 1,398,499 I
Open-market sales · 100,000 sh · avg $12.93 · $1,293,205
Loading xslF345X05/form4-09192024_080917.xml…